NCT01219335

Brief Summary

Use of discarded embryos to advance laboratory expertise and technology in the area of human embryo development and assisted reproductive technologies

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
42mo left

Started Apr 2003

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Apr 2003Dec 2029

Study Start

First participant enrolled

April 1, 2003

Completed
7.5 years until next milestone

First Submitted

Initial submission to the registry

October 8, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 13, 2010

Completed
18.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

June 3, 2026

Status Verified

June 1, 2026

Enrollment Period

25.7 years

First QC Date

October 8, 2010

Last Update Submit

June 1, 2026

Conditions

Keywords

IVF

Outcome Measures

Primary Outcomes (1)

  • Methods for freezing -embryos

    To test, standardize and implement better methods for the freezing embryos prior to these techniques being used in the clinical setting

    duration of the study

Secondary Outcomes (2)

  • Development non-invasive tests

    duration of the study

  • Factors that control embryo development

    duration of the study

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients undergoing infertility treatment

You may qualify if:

  • none

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reproductive Medicine Associates of new Jersey

Basking Ridge, New Jersey, 07920, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Discarded non-viable oocytes, granulosa cells, spermatozoa, developmentally arrested embryos, serum, follicular fluid, and conditioned IVF media.

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Thomas Molinaro, MD, MSCE

    Reproductive Medicine Associates of New Jersey

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christine V Whitehead, BSN, RN

CONTACT

Caroline Zuckerman, RN

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2010

First Posted

October 13, 2010

Study Start

April 1, 2003

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2029

Last Updated

June 3, 2026

Record last verified: 2026-06

Locations